Skip to content
Biodatica
Start free

Investigator

Jin Xie

UNIVERSITY OF GEORGIA · funded by NCI, NIDCR

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.2M

Summed across those awards.

First award
Jun 14, 2021

Latest Mar 24, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Calcium Nanoparticles to Enhance Immuno-Radiotherapy

    $618k

    Mar 24, 2026NCIUNIVERSITY OF GEORGIANIH RePORTER · 11297116 (opens the source filing in a new tab)

  2. R01

    Engineered Synthetic Low-Density Lipoprotein Nanoparticles for Enhanced Cancer Immunotherapy in Head and Neck Cancer

    $644k

    Mar 1, 2026NIDCRUNIVERSITY OF GEORGIANIH RePORTER · 11275898 (opens the source filing in a new tab)

  3. R42

    Development of a radiation-activatable nanoparticle for lung cancer therapy

    $901k

    Jun 14, 2021NCIATHNA BIOTECH, INC.NIH RePORTER · 11254781 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources